Lipids

Cholesterol esters (CEs) can modulate membrane fluidity and bilayer thickness upon interacting with triacylglycerols (TAGs) and phospholipids (PLs). Unsaturated esters such as these have been shown to affect the liquid crystalline phases of these type of lipids. Formulation of CEs into lipid nanoparticles may serve to tune the physical properties of lipid nanoparticles for delivery applications. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.

Cholesterol esters (CEs) can modulate membrane fluidity and bilayer thickness upon interacting with triacylglycerols (TAGs) and phospholipids (PLs). Unsaturated esters such as these have been shown to affect the liquid crystalline phases of these type of lipids. Formulation of CEs into lipid nanoparticles may serve to tune the physical properties of lipid nanoparticles for delivery applications. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.

Cholesterol esters (CEs) can modulate membrane fluidity and bilayer thickness upon interacting with triacylglycerols (TAGs) and phospholipids (PLs). Unsaturated esters such as these have been shown to affect the liquid crystalline phases of these type of lipids. Formulation of CEs into lipid nanoparticles may serve to tune the physical properties of lipid nanoparticles for delivery applications. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.

Cholesterol esters (CEs) can modulate membrane fluidity and bilayer thickness upon interacting with triacylglycerols (TAGs) and phospholipids (PLs). Unsaturated esters such as these have been shown to affect the liquid crystalline phases of these type of lipids. Formulation of CEs into lipid nanoparticles may serve to tune the physical properties of lipid nanoparticles for delivery applications. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.

Cholesterol esters (CEs) can modulate membrane fluidity and bilayer thickness upon interacting with triacylglycerols (TAGs) and phospholipids (PLs). Unsaturated esters such as these have been shown to affect the liquid crystalline phases of these type of lipids. Formulation of CEs into lipid nanoparticles may serve to tune the physical properties of lipid nanoparticles for delivery applications. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.

An ionizable lipid analog of CL1H6 featuring a two biodegredable ester linkages to palmitoleic acid (16:1) tails. Additional features include a core hydroxyl group to promote hydrogen-bonding with neighboring lipids. This compound may be used in the formulation of lipid nanoparticles (LNP's) for delivery applications. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.

An ionizable lipid featuring a two biodegredable ester linkages to unsaturated linoleic acid (18:2) tails. Additional features include a core hydroxyl group to promote hydrogen-bonding with neighboring lipids. This compound may be used in the formulation of lipid nanoparticles (LNP's) for delivery applications. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.

An oleic acid (18:1) derived phospholipid part of the cardiolipin (CL) class of lipids. CLs such as these have been shown to exhibit organ-specific delivery of encapsulated mRNA at the expense of general efficacy. These lipids may be formulated into lipid nanoparticles for mRNA delivery research. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.

A dipalmitoylphosphatidylglycerol derivative featuring a single isotopically-labeled palmitic acid tail at the sn-1 position. Labeled phospholipids may be used to study membrane dynamics and or lipid metabolism. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.